Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mindstrong developed a digital biomarker platform leveraging AI to analyze passive smartphone data for real-time assessment of cognitive function and mood. The company later pivoted to providing app-based virtual mental healthcare targeting serious mental illness. Despite raising over $160 million from top investors and demonstrating innovative technology with several patents granted, the company ceased operations in early 2023 due to challenges with business model sustainability in the U.S. healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mindstrong.